Serum Institute defends vaccine pricing, says initial rates based on advance funding

Serum Institute of India (SII), which manufactures AstraZeneca's vaccine Covishield at its Pune facility, earlier this week announced a price of Rs 600 per dose and at Rs 400 for state governments and any new contract by the central government.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2QsKpxg
via IFTTT